STOCK TITAN

Generac's Norman P. Taffe sells 550 shares

President Generac Home's reported sales were under a Rule 10b5-1(c) plan adopted on March 6, 2026.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Generac Holdings Inc. reported that President Generac Home Norman P. Taffe exercised options covering 100 shares on October 5, 2026, and 150 shares on October 6, 2026, at an exercise price of $119.54 per share. He sold 550 shares: 400 shares at $215.46 per share on October 5 and 150 shares at $220 per share on October 6. The sales were made under a Rule 10b5-1(c) plan adopted on March 6, 2026.

Insights

Analyzing...

Insider Taffe Norman P
Role President Generac Home
Sold 550 shs ($119K)
Approx. gross sale proceeds $119K
Approx. exercise cost $30K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3 150 $0.00 $0.00
Exercise Common Stock F1 150 $119.54 $18K
Sale Common Stock F1 150 $220.00 $33K
Exercise Stock Option (Right to Buy) F3 100 $0.00 $0.00
Sale Common Stock F1, F2 200 $215.46 $43K
Sale Common Stock F1, F2 100 $215.46 $22K
Exercise Common Stock F1 100 $119.54 $12K
Sale Common Stock F1, F2 100 $215.46 $22K
Holdings After Transaction: Stock Option (Right to Buy) — 1,870 contracts (Direct); Common Stock — 10,976 shares (Direct)
Footnotes (3)
  1. F1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
  2. F2. Multiple lots for the same price for this order have been combined.
  3. F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
Options exercised 100 shares October 5, 2026; exercise price $119.54 per share
Options exercised 150 shares October 6, 2026; exercise price $119.54 per share
Exercise price $119.54 per share Options exercised October 5 and 6, 2026
Shares sold 400 shares October 5, 2026, at $215.46 per share
Shares sold 150 shares October 6, 2026, at $220 per share
Rule 10b5-1(c) plan regulatory
"Adoption date of referenced 10b5-1(c) plan"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
graded vesting schedule technical
"Grant has a graded vesting schedule"
vesting tranche technical
"Date exercisable will vary for each vesting tranche"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GNRC options did President Generac Home Norman P. Taffe exercise?

Taffe exercised options covering 100 shares on October 5, 2026, and 150 shares on October 6, 2026. The reported exercise price was $119.54 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Taffe Norman P

(Last)(First)(Middle)
S45 W29290 HWY.59
C/O GENERAC HOLDINGS INC.

(Street)
WAUKESHA WISCONSIN 53189

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President Generac Home
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/05/2026S(1)(2)200D$215.4611,076D
Common Stock10/05/2026S(1)(2)100D$215.4610,976D
Common Stock10/05/2026M(1)100A$119.5411,076D
Common Stock10/05/2026S(1)(2)100D$215.4610,976D
Common Stock10/06/2026M(1)150A$119.5411,126D
Common Stock10/06/2026S(1)150D$22010,976D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$119.5410/05/2026M100 (3)03/01/2033Common Stock100$02,020D
Stock Option (Right to Buy)$119.5410/06/2026M150 (3)03/01/2033Common Stock150$01,870D
Explanation of Responses:
1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
2. Multiple lots for the same price for this order have been combined.
3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
/s/ Raj Kanuru, Attorney in Fact10/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading